GROSSO, Federica
 Distribuzione geografica
Continente #
NA - Nord America 1.169
EU - Europa 700
AS - Asia 324
OC - Oceania 25
AF - Africa 12
SA - Sud America 4
Totale 2.234
Nazione #
US - Stati Uniti d'America 1.152
IT - Italia 319
CN - Cina 159
IE - Irlanda 70
SE - Svezia 55
GB - Regno Unito 47
DK - Danimarca 40
SG - Singapore 38
AT - Austria 37
FR - Francia 29
IN - India 25
AU - Australia 24
JP - Giappone 22
DE - Germania 21
CA - Canada 16
VN - Vietnam 15
PL - Polonia 11
BE - Belgio 10
ES - Italia 10
UA - Ucraina 10
HK - Hong Kong 9
IL - Israele 8
TH - Thailandia 8
CH - Svizzera 6
IQ - Iraq 6
TW - Taiwan 6
FI - Finlandia 5
IR - Iran 5
NL - Olanda 5
RO - Romania 5
TR - Turchia 5
KR - Corea 4
PH - Filippine 4
ZA - Sudafrica 4
BR - Brasile 3
CZ - Repubblica Ceca 3
GR - Grecia 3
ID - Indonesia 3
NO - Norvegia 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
NG - Nigeria 2
AL - Albania 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CY - Cipro 1
EG - Egitto 1
ET - Etiopia 1
HU - Ungheria 1
KE - Kenya 1
KZ - Kazakistan 1
LI - Liechtenstein 1
MM - Myanmar 1
MX - Messico 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
RS - Serbia 1
RU - Federazione Russa 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
UG - Uganda 1
Totale 2.234
Città #
Ann Arbor 177
Chandler 121
Torino 82
Fairfield 79
Dublin 69
Redwood City 57
Ashburn 52
Houston 46
Seattle 43
Beijing 40
Woodbridge 39
Turin 35
Vienna 33
Wilmington 31
Nyköping 30
Cambridge 27
Dearborn 26
Pisa 22
Singapore 21
New York 18
Medford 17
Milan 17
Princeton 15
Shanghai 12
Dong Ket 10
Warsaw 10
Boardman 9
Chicago 8
London 8
Rome 8
Florence 7
Fremont 7
Tokyo 7
Villeurbanne 7
Washington 7
Boston 6
Genoa 6
Guangzhou 6
Hangzhou 6
Perth 6
San Diego 6
Chengdu 5
Frankfurt am Main 5
Nanjing 5
Paris 5
Robbio 5
San Mauro Torinese 5
Shenyang 5
Abbotsford 4
Atlanta 4
Bangkok 4
Bologna 4
Brussels 4
Changsha 4
Dallas 4
Duncan 4
Greenford 4
Kunming 4
Los Angeles 4
Mumbai 4
Ottawa 4
Redmond 4
Taipei 4
Trieste 4
Ahmedabad 3
Amsterdam 3
Buffalo 3
Canberra 3
Central District 3
Collegeville 3
Helsinki 3
Honolulu 3
Jacksonville 3
Kwinana 3
Las Vegas 3
Lexington 3
Montreal 3
Naples 3
New Delhi 3
Philadelphia 3
Piscataway 3
Portland 3
Sheffield 3
Siena 3
Suzhou 3
Sydney 3
Toulouse 3
Upper Marlboro 3
Xian 3
Abuja 2
Alessandria 2
Antwerp 2
Arbil 2
Bari 2
Biassono 2
Borgomanero 2
Bulandshahr 2
Cagliari 2
Changchun 2
Chiang Mai 2
Totale 1.429
Nome #
Nintedanib plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma: Phase II results from the randomized, placebo-controlled lume-meso trial 469
L’impatto psicologico dell’amianto, killer invisibile del corpo e della mente. 272
Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma 238
Wnt/IL-1β/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5 224
Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma. 204
Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects 145
"The less i think about it, the better i feel": A thematic analysis of the subjective experience of Malignant Mesothelioma patients and their caregivers 138
Psychological Distress after a Diagnosis of Malignant Mesothelioma in a Group of Patients and Caregivers at the National Priority Contaminated Site of Casale Monferrato 114
Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes 91
Dna methylation of fkbp5 as predictor of overall survival in malignant pleural mesothelioma 90
SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma 60
New DNA methylation signals for malignant pleural mesothelioma risk assessment 56
Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment 49
Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial 42
Diagnostics of BAP1-Tumor Predisposition Syndrome by a Multitesting Approach: A Ten-Year-Long Experience 41
Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group 25
Preliminary validation of a brief PROM assessing psychological distress in patients with malignant mesothelioma: The mesothelioma psychological distress tool-Patients 24
Unprecedented long-term survival in a patient with malignant pleural mesothelioma treated with subsequent systemic chemo- and immunotherapeutic regimens 6
Confirmatory validation of the Mesothelioma Psychological Distress Tool—Patients: A brief patient‐reported outcome measure assessing psychological distress in malignant mesothelioma patients 3
BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report 2
Totale 2.293
Categoria #
all - tutte 6.518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.518


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020356 15 8 13 37 23 36 30 43 42 40 31 38
2020/2021441 33 35 41 48 41 66 26 40 20 35 19 37
2021/2022439 37 32 34 48 27 26 39 26 29 26 66 49
2022/2023468 31 31 18 39 33 96 19 32 74 29 41 25
2023/2024342 43 48 23 24 29 38 23 13 9 30 36 26
2024/202513 13 0 0 0 0 0 0 0 0 0 0 0
Totale 2.293